Bulk Orders 20+ bottles
Volume pricing applies automatically from three bottles and reaches 20% at twenty. Larger runs, institutional supply and custom timelines get a quote.
Ask about bulk
Neurocognitive Research
Fladrafinil, also known as CRL-40,941, is a capsule research product. It has 50MG per capsule and 60 capsules per bottle. That is 3,000MG total content. It is made for controlled lab work in afinil analog research, benzhydryl sulfinyl compound models and wakefulness pathways.
Bundle & save
Referral program · researchers save 10%, you earn 15% backThe compounds researchers order most, by verified order volume.
More ways to save
Volume pricing applies automatically from three bottles and reaches 20% at twenty. Larger runs, institutional supply and custom timelines get a quote.
Ask about bulkShipping batch CRL01
Open the certificate matched to this shipping batch.
Verified test results
Each batch is analyzed by Freedom Diagnostics, an independent third-party laboratory, before release. Below is the report for lot CRL01, summarized from the certificate the lab published.
This lot ships under its own published certificate. Open any certificate below, exactly as the lab released it.
Side by side
Technical specifications
Important research notice
Not for human, veterinary, or food use. This product is sold exclusively for laboratory research purposes. It is not intended to diagnose, treat, cure, or prevent any disease, and has not been evaluated by the FDA.
All referenced publications and registries are sourced from peer-reviewed journals and official registries. They are provided for educational reference only and are not product claims.
By purchasing, you confirm you are a qualified researcher and will handle this product in accordance with all applicable laws and regulations.
Ready when you are
The lot on this page links to the signed certificate for that batch.
Encapsulated research material
Fladrafinil, also known as CRL-40,941, is a capsule research product. It has 50MG per capsule and 60 capsules per bottle. That is 3,000MG total content. It is made for controlled lab work in afinil analog research, benzhydryl sulfinyl compound models and wakefulness pathways. It also fits monoamine signaling and CNS pathway studies. The same goes for neurochemical response models and compound response screening.
We supply Fladrafinil as a finished capsule research product. It is for labs that want a clear 50MG strength label and clearly stated total content. The capsules look clean. It also gets internal QA review and direct in-house fulfillment.
| Compound | Fladrafinil |
|---|---|
| Also Known As | CRL-40,941 / Fluorafinil / Bisfluoroadrafinil |
| Strength | 50MG per capsule |
| Count | 60 capsules |
| Total Content | 3,000MG Fladrafinil |
| Format | Capsule research product |
Afinil Analog Research Format
Fladrafinil is studied in controlled lab models. These cover afinil analog pathways and compounds close to modafinil. Others look at CNS response, monoamine signaling and neurochemical activity.
It is studied in models of analogs from the afinil class. Benzhydryl sulfinyl compounds are another focus. Other models look at CNS pathway activity and compound response screening.
It fits lab studies of neurochemical response and wakefulness pathways. It also fits monoamine signaling and receptor-adjacent response systems.
The 50MG capsule strength is shown clearly. Each bottle holds 60 capsules, for 3,000MG total content.
It is studied in lab models of afinil analogs and of pathways close to modafinil. It is also used in models of monoamine signaling and CNS response. Other models look at neurochemical activity and wakefulness.
Research on Fladrafinil looks at how CRL-40,941 may behave in controlled CNS pathway models. The same question comes up in benzhydryl sulfinyl compound studies and neurochemical response systems. It also comes up in compound screening work under structured lab conditions.
The 50MG, 60 capsule format gives researchers a clearly labeled capsule product. It holds 3,000MG in total, for organized records and lab handling.
Retain the product label and lot number with the research record. Review the matching certificate of analysis for test coverage and reported results. Identity, analytical purity, measured content, sterility and endotoxin testing are distinct assessments; one does not establish the others.
Follow the supplied label and your laboratory’s validated handling and storage procedures. Record the vehicle, concentration and preparation date where relevant. Dry-material stability does not establish the shelf life of a prepared solution.
It is the stated quantity per unit, separate from the number of units in the bottle. A purity percentage is not a measurement of milligrams per capsule or tablet. Use the matching lot report for the measurements actually performed.
Open the linked certificate for the assigned lot or use the COA portal. Check sample identity, methods, date and reported measurements. A report for another lot or formulation is not a substitute.
Fladrafinil, code CRL-40,941, is 2-[bis(4-fluorophenyl)methylsulfinyl]-N-hydroxyacetamide, C₁₅H₁₃F₂NO₃S at 325.3 g/mol in PubChem: adrafinil, 2-benzhydrylsulfinyl-N-hydroxyacetamide, with a fluorine atom on each phenyl ring. Laboratoire L. Lafon, the French company that identified adrafinil in 1974, describes it as CRL 40941 in a 1984 US patent on halogenated derivatives.
A 2026 Cologne doping-control paper calls fladrafinil and flmodafinil bisfluorinated analogs of adrafinil and modafinil, adrafinil being modafinil's N-hydroxy derivative and prodrug, and reports that, similar to adrafinil, fladrafinil is a prodrug metabolized to flmodafinil. Its elimination study measured both compounds and their metabolites in urine and dried blood spots from six healthy volunteers, three men and three women.
In competition, yes. WADA added fladrafinil and flmodafinil to S6.A, non-specified stimulants, in its 2026 Prohibited List, which names fladrafinil with its chemical name; S6 substances are prohibited in-competition, and adrafinil and modafinil are listed in the same section. Drugs@FDA lists no product containing fladrafinil (openFDA search, 15 October 2026).
This page sells Fladrafinil, also known as CRL-40,941, as a capsule research product supplied at 50MG per capsule with 60 capsules per bottle. Each batch is analyzed by Freedom Diagnostics before release, and this lot ships under its own published certificate. It is sold exclusively for laboratory research purposes and ships from the US West Coast, by FedEx 2-Day shipping.
The current certificate is matched to the selected product option and assigned shipping batch.
Enable JavaScript to view the certificate for your selected option.
We share visit and purchase data with advertising partners to measure and show ads. Some US state laws, including California's, call that a sale or sharing of personal information. You can turn it off for this browser.
Ad sharing is on in this browser.
Saved in this browser only. For your account or other devices, email support@disguisedalpha.com. Privacy Policy